Clinical Trial Update: Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy

View source ↗

Summary

A completed Bristol-Myers Squibb-sponsored study in Chinese patients with chronic hepatitis B examines rescue treatment patterns, recurrence of drug resistance,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis B | Status: COMPLETED